Development of maraviroc, a CCR5 antagonist for treatment of HIV, using a novel tropism assay.

MLA

van der Ryst, Elna, et al. “Development of Maraviroc, a CCR5 Antagonist for Treatment of HIV, Using a Novel Tropism Assay.” Annals of the New York Academy of Sciences, vol. 1346, no. 1, June 2015, pp. 7–17. EBSCOhost, https://doi.org/10.1111/nyas.12777.

APA

van der Ryst, E., Heera, J., Demarest, J., & Knirsch, C. (2015). Development of maraviroc, a CCR5 antagonist for treatment of HIV, using a novel tropism assay. Annals of the New York Academy of Sciences, 1346(1), 7–17. https://doi.org/10.1111/nyas.12777

Chicago

van der Ryst, Elna, Jayvant Heera, James Demarest, and Charles Knirsch. 2015. “Development of Maraviroc, a CCR5 Antagonist for Treatment of HIV, Using a Novel Tropism Assay.” Annals of the New York Academy of Sciences 1346 (1): 7–17. doi:10.1111/nyas.12777.